Kitov Pharma (NASDAQ:KTOV) stock has surged at the start of the US session after they announced that the European Patent Office intends to grant a new patent to the company for the application entitled “Humanized antibodies against CEACAM1.”
The clinical-stage company said that the patent covers “protein and DNA sequences pertaining to humanized antibodies.”
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Kitov’s Chief Executive Officer, Isaac Israel Said “We are very pleased with this new addition to our patent coverage in the EU, which, together with the corresponding US patent which has been granted earlier this year, strongly positions CM24 as a unique approach for treating cancer patients. We look forward to the anticipated initiation of our planned Phase 1/2 clinical trial with BMS later this year.”
Just a couple of weeks ago the company’s share price skyrocketed after Barstool Sports President and day trader Dave Portnoy said he was buying the stock, leading to a mass of other day traders that follow him climbing on board.
The stock ended up rising by 51%, with the following day seeing another rise of 46% as the company announced it closed its registered direct offering of 38,888,892 of ordinary shares, raising approximately $35 million as they looked to capitalise on the recent rise.
At the open Kitov’s shares were trading at $0.94. However, they have retraced and are now trading “just” 10.67% higher, $0.87.
